Clinical Trial Update: Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the Extracorporeal Liver Assist System (ELAD) in acute alcoholic hepatitis has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• ELAD (Extracorporeal Liver Assist System)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Acute Alcoholic Hepatitis | Phase 3 | Status: COMPLETED | Results posted: 2019-02-15